Search Results - "Mario Amaya-Guerra"
-
1
The molecular basis of dystrophic epidermolysis bullosa in Mexico
Published in International journal of dermatology (01-06-2000)“…Background Type VII collagen gene (COL7A1) mutations are the cause of dystrophic epidermolysis bullosa (DEB), but most mutations are specific to individual…”
Get full text
Journal Article -
2
Efficacy of Tofacitinib for the Treatment of Moderate-to-Severe Chronic Plaque Psoriasis in Patient Subgroups from Two Randomised Phase 3 Trials
Published in Journal of drugs in dermatology (01-05-2016)“…Tofacitinib is a Janus kinase inhibitor being investigated for the treatment of moderate-to-severe plaque psoriasis. We report efficacy of tofacitinib in…”
Get more information
Journal Article -
3
Expert recommendations for biological treatment in patients with psoriasis
Published in Gaceta médica de México (2020)“…In recent years, the introduction of a series of biological drugs for the treatment of psoriasis has considerably increased the therapeutic armamentarium of…”
Get full text
Journal Article -
4
Recommendations of the Mexican College of Rheumatology for the management of psoriatic arthritis
Published in Reumatología clinica (Barcelona) (01-12-2021)“…Psoriatic arthritis is a chronic systemic inflammatory disease that affects the skin, musculoskeletal structures and other organs and systems compromising…”
Get full text
Journal Article -
5
Recommendations of the Mexican College of Rheumatology for the management of psoriatic arthritis
Published in Reumatología clinica (Barcelona) (01-12-2021)“…Psoriatic arthritis is a chronic systemic inflammatory disease that affects the skin, musculoskeletal structures and other organs and systems compromising…”
Get full text
Journal Article -
6
Recommendations of the Mexican College of Rheumatology for the management of psoriatic arthritis
Published in Reumatología clinica (Barcelona) (01-12-2021)“…Psoriatic arthritis is a chronic systemic inflammatory disease that affects the skin, musculoskeletal structures and other organs and systems compromising…”
Get full text
Journal Article -
7
Guía de dermatitis atópica para México (GUIDAMEX): lineamientos usando metodología ADAPTE
Published in Gaceta médica de México (01-01-2022)Get full text
Journal Article -
8
Expert recommendations for biological treatment in patients with psoriasis
Published in Gaceta médica de México (31-03-2023)Get full text
Journal Article -
9
Recomendaciones del Colegio Mexicano de Reumatología para el manejo de la artritis psoriásica
Published in Reumatología clinica (01-12-2021)“…La artritis psoriásica (APs) es una enfermedad inflamatoria sistémica crónica que afecta a la piel, las estructuras musculoesqueléticas y otros órganos y…”
Get full text
Journal Article -
10
Recomendaciones de expertos para el tratamiento biológico en pacientes con psoriasis
Published in Gaceta médica de México (08-10-2020)Get full text
Journal Article -
11
Guía de dermatitis atópica para México (GUIDAMEX): lineamientos usando metodología ADAPTE
Published in Gaceta médica de México (14-02-2023)Get full text
Journal Article -
12
Guidelines on atopic dermatitis for Mexico (GUIDAMEX): using the ADAPTE methodology
Published in Gaceta médica de México (20-01-2023)Get full text
Journal Article -
13
Mexican Guidelines on the Diagnosis and Treatment of Urticaria
Published in Revista alergia Mexico (Tecamachalco, Pueblo, Mexico : 1993) (01-11-2014)“…Background: Urticaria is a disease that a fth of the population shall suffer once in a lifetime. Recent clinical guidelines have proposed some fundamental…”
Get full text
Journal Article -
14
Mutation in the ED1, Ala349Thr in a patient with X-linked hypohidrotic ectodermal dysplasia
Published in Revista medíca de Chile (01-12-2011)“…Hypohidrotic ectodermal dysplasia (HED) is a very rare disease characterized by the absence of eccrine glands, dry skin, scanty hair, and dental abnormalities…”
Get full text
Journal Article -
15
Mutación en el gen EDA1, Ala349Thr en paciente con displasia ectodérmica hipohidrótica ligada a X
Published in Revista medíca de Chile (01-12-2011)Get full text
Journal Article -
16
Control of Moderate‐to‐Severe Plaque Psoriasis with Efalizumab: 24‐Week, Open‐Label, Phase IIIb/IV Latin American Study Results
Published in Archives of drug information (01-12-2009)“…ABSTRACT Introduction. Psoriasis is a debilitating, chronic inflammatory systemic disease affecting around 2% of the South American population. Biological…”
Get full text
Journal Article -
17
The molecular basis of dystrophic epidermoylsis bullosa in Mexico
Published in International journal of dermatology (01-06-2000)Get full text
Journal Article -
18
Guía mexicana para el diagnóstico y el tratamiento de la urticaria
Published in Revista alergia Mexico (Tecamachalco, Pueblo, Mexico : 1993) (30-11-2014)“…Antecedentes: la urticaria es una enfermedad que padece una quinta parte de la población en algún momento de su vida. Las guías internacionales recientes han…”
Get full text
Journal Article -
19
Mexican treatment goals for plaque psoriasis
Published in Revista médica (Mexico : 1983) (01-01-2017)“…Psoriasis is a chronic inflammatory disease with a worldwide prevalence between 6 and 39% in moderate to severe forms. In European countries like Germany and…”
Get full text
Journal Article -
20
Wiskott Aldrich syndrome associated to vasculitis: a therapeutic challenge
Published in Revista alergia Mexico (Tecamachalco, Pueblo, Mexico : 1993) (01-01-2012)“…Wiskott Aldrich syndrome (WAS) is an X-linked primary immunodeficiency, associated with WASP gene mutation that causes severe immunological abnormalities and…”
Get full text
Journal Article